US Drug Recall Register
Class II · Moderate risk Terminated Initiated Mar 30, 2020 (6 years ago)

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specification: Presence of unknown impurity observed.

What was recalled

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01

Recalling firm
Par Pharmaceutical Inc.
NDC code
49884-0065-01
Origin
NY, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1071-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glycopyrrolate recalls

See all